Viral clearance and escape during therapy of COVID-19 outpatients: A prospective cohort study

DOI record: { "DOI": "10.1016/j.isci.2025.114226", "ISSN": [ "2589-0042" ], "URL": "http://dx.doi.org/10.1016/j.isci.2025.114226", "alternative-id": [ "S2589004225024873" ], "article-number": "114226", "assertion": [ { "label": "This article is maintained by", "name": "publisher", "value": "Elsevier" }, { "label": "Article Title", "name": "articletitle", "value": "Viral clearance and escape during therapy of COVID-19 outpatients: A prospective cohort study" }, { "label": "Journal Title", "name": "journaltitle", "value": "iScience" }, { "label": "CrossRef DOI link to publisher maintained version", "name": "articlelink", "value": "https://doi.org/10.1016/j.isci.2025.114226" }, { "label": "Content Type", "name": "content_type", "value": "article" }, { "label": "Copyright", "name": "copyright", "value": "© 2025 The Author(s). Published by Elsevier Inc." } ], "author": [ { "affiliation": [], "family": "Martin-Blondel", "given": "Guillaume", "sequence": "first" }, { "affiliation": [], "family": "Burgat", "given": "Paul", "sequence": "additional" }, { "affiliation": [], "family": "Leducq", "given": "Valentin", "sequence": "additional" }, { "affiliation": [], "family": "Porrot", "given": "Françoise", "sequence": "additional" }, { "affiliation": [], "family": "Cottignies-Calamarte", "given": "Andrea", "sequence": "additional" }, { "affiliation": [], "family": "De Cruz", "given": "Alejandro", "sequence": "additional" }, { "affiliation": [], "family": "Dorival", "given": "Céline", "sequence": "additional" }, { "affiliation": [], "family": "Romieu-Mourez", "given": "Raphaelle", "sequence": "additional" }, { "affiliation": [], "family": "Chaubet", "given": "Camille", "sequence": "additional" }, { "affiliation": [], "family": "Cazaentre", "given": "Vincent", "sequence": "additional" }, { "affiliation": [], "family": "Boumaza", "given": "Xavier", "sequence": "additional" }, { "affiliation": [], "family": "Richier", "given": "Quentin", "sequence": "additional" }, { "affiliation": [], "family": "Gaborit", "given": "Benjamin", "sequence": "additional" }, { "affiliation": [], "family": "Coustilleres", "given": "Francois", "sequence": "additional" }, { "affiliation": [], "family": "Dubée", "given": "Vincent", "sequence": "additional" }, { "affiliation": [], "family": "Ader", "given": "Florence", "sequence": "additional" }, { "affiliation": [], "family": "Yordanov", "given": "Youri", "sequence": "additional" }, { "affiliation": [], "family": "Schwartz", "given": "Olivier", "sequence": "additional" }, { "affiliation": [], "family": "Marcelin", "given": "Anne-Geneviève", "sequence": "additional" }, { "affiliation": [], "family": "Lusivika-Nzinga", "given": "Clovis", "sequence": "additional" }, { "affiliation": [], "family": "Carrat", "given": "Fabrice", "sequence": "additional" }, { "affiliation": [], "family": "Soulié", "given": "Cathia", "sequence": "additional" }, { "affiliation": [], "family": "Liblau", "given": "Roland", "sequence": "additional" }, { "affiliation": [], "family": "Bruel", "given": "Timothée", "sequence": "additional" } ], "container-title": "iScience", "container-title-short": "iScience", "content-domain": { "crossmark-restriction": true, "domain": [ "cell.com", "elsevier.com", "sciencedirect.com" ] }, "created": { "date-parts": [ [ 2025, 11, 26 ] ], "date-time": "2025-11-26T16:50:16Z", "timestamp": 1764175816000 }, "deposited": { "date-parts": [ [ 2026, 1, 20 ] ], "date-time": "2026-01-20T18:29:13Z", "timestamp": 1768933753000 }, "funder": [ { "DOI": "10.13039/501100014630", "doi-asserted-by": "publisher", "id": [ { "asserted-by": "publisher", "id": "10.13039/501100014630", "id-type": "DOI" } ], "name": "Ministère des Solidarités et de la Santé" }, { "DOI": "10.13039/501100011045", "doi-asserted-by": "publisher", "id": [ { "asserted-by": "publisher", "id": "10.13039/501100011045", "id-type": "DOI" } ], "name": "Ministère de l'Enseignement supérieur, de la Recherche et de l'Innovation" }, { "DOI": "10.13039/501100001665", "award": [ "ANR-23-CE15-0039-01" ], "award-info": [ { "award-number": [ "ANR-23-CE15-0039-01" ] } ], "doi-asserted-by": "publisher", "id": [ { "asserted-by": "publisher", "id": "10.13039/501100001665", "id-type": "DOI" } ], "name": "French National Research Agency" } ], "indexed": { "date-parts": [ [ 2026, 1, 21 ] ], "date-time": "2026-01-21T07:21:01Z", "timestamp": 1768980061393, "version": "3.49.0" }, "is-referenced-by-count": 0, "issue": "12", "issued": { "date-parts": [ [ 2025, 12 ] ] }, "journal-issue": { "issue": "12", "published-print": { "date-parts": [ [ 2025, 12 ] ] } }, "language": "en", "license": [ { "URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2025, 12, 1 ] ], "date-time": "2025-12-01T00:00:00Z", "timestamp": 1764547200000 } }, { "URL": "https://www.elsevier.com/legal/tdmrep-license", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2025, 12, 1 ] ], "date-time": "2025-12-01T00:00:00Z", "timestamp": 1764547200000 } }, { "URL": "http://creativecommons.org/licenses/by/4.0/", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2025, 11, 21 ] ], "date-time": "2025-11-21T00:00:00Z", "timestamp": 1763683200000 } } ], "link": [ { "URL": "https://api.elsevier.com/content/article/PII:S2589004225024873?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://api.elsevier.com/content/article/PII:S2589004225024873?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining" } ], "member": "78", "original-title": [], "page": "114226", "prefix": "10.1016", "published": { "date-parts": [ [ 2025, 12 ] ] }, "published-print": { "date-parts": [ [ 2025, 12 ] ] }, "publisher": "Elsevier BV", "reference": [ { "article-title": "Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study", "author": "Evans", "journal-title": "Lancet Reg. Health. Eur.", "key": "10.1016/j.isci.2025.114226_bib1", "volume": "35", "year": "2023" }, { "DOI": "10.1016/j.jinf.2024.01.009", "article-title": "Disparities in COVID-19 mortality amongst the immunosuppressed: A systematic review and meta-analysis for enhanced disease surveillance", "author": "Leston", "doi-asserted-by": "crossref", "journal-title": "J. Infect.", "key": "10.1016/j.isci.2025.114226_bib2", "volume": "88", "year": "2024" }, { "DOI": "10.1126/scitranslmed.adk1599", "article-title": "SARS-CoV-2 viral clearance and evolution varies by type and severity of immunodeficiency", "author": "Li", "doi-asserted-by": "crossref", "journal-title": "Sci. Transl. Med.", "key": "10.1016/j.isci.2025.114226_bib3", "volume": "16", "year": "2024" }, { "DOI": "10.1016/j.cell.2020.10.049", "article-title": "Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer", "author": "Avanzato", "doi-asserted-by": "crossref", "first-page": "1901", "journal-title": "Cell", "key": "10.1016/j.isci.2025.114226_bib4", "volume": "183", "year": "2020" }, { "DOI": "10.1056/NEJMc2031364", "article-title": "Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host", "author": "Choi", "doi-asserted-by": "crossref", "first-page": "2291", "journal-title": "N. Engl. J. Med.", "key": "10.1016/j.isci.2025.114226_bib5", "volume": "383", "year": "2020" }, { "DOI": "10.1038/s41586-021-03291-y", "article-title": "SARS-CoV-2 evolution during treatment of chronic infection", "author": "Kemp", "doi-asserted-by": "crossref", "first-page": "277", "journal-title": "Nature", "key": "10.1016/j.isci.2025.114226_bib6", "volume": "592", "year": "2021" }, { "DOI": "10.1056/NEJMsb2104756", "article-title": "SARS-CoV-2 Variants in Patients with Immunosuppression", "author": "Corey", "doi-asserted-by": "crossref", "first-page": "562", "journal-title": "N. Engl. J. Med.", "key": "10.1016/j.isci.2025.114226_bib7", "volume": "385", "year": "2021" }, { "DOI": "10.1016/S2666-5247(23)00194-5", "article-title": "Determinants of passive antibody efficacy in SARS-CoV-2 infection: a systematic review and meta-analysis", "author": "Stadler", "doi-asserted-by": "crossref", "first-page": "e883", "journal-title": "Lancet Microbe", "key": "10.1016/j.isci.2025.114226_bib8", "volume": "4", "year": "2023" }, { "DOI": "10.1093/jac/dkae301", "article-title": "Antiviral effect of Evusheld in COVID-19 hospitalized patients infected with pre-Omicron or Omicron variants: a modelling analysis of the randomized DisCoVeRy trial", "author": "Beaulieu", "doi-asserted-by": "crossref", "first-page": "2887", "journal-title": "J. Antimicrob. Chemother.", "key": "10.1016/j.isci.2025.114226_bib9", "volume": "79", "year": "2024" }, { "DOI": "10.1136/bmj-2022-071932", "article-title": "Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study with the OpenSAFELY platform", "author": "Zheng", "doi-asserted-by": "crossref", "journal-title": "BMJ", "key": "10.1016/j.isci.2025.114226_bib10", "volume": "379", "year": "2022" }, { "DOI": "10.1172/JCI168603", "article-title": "SARS-CoV-2 variants resistant to monoclonal antibodies in immunocompromised patients constitute a public health concern", "author": "Casadevall", "doi-asserted-by": "crossref", "journal-title": "J. Clin. Investig.", "key": "10.1016/j.isci.2025.114226_bib11", "volume": "133", "year": "2023" }, { "DOI": "10.1016/j.drup.2023.100991", "article-title": "Analysis of SARS-CoV-2 mutations associated with resistance to therapeutic monoclonal antibodies that emerge after treatment", "author": "Focosi", "doi-asserted-by": "crossref", "journal-title": "Drug Resist. Updat.", "key": "10.1016/j.isci.2025.114226_bib12", "volume": "71", "year": "2023" }, { "DOI": "10.1093/infdis/jiad523", "article-title": "Spike Protein Genetic Evolution in Patients at High Risk of Severe Coronavirus Disease 2019 Treated by Monoclonal Antibodies", "author": "Leducq", "doi-asserted-by": "crossref", "first-page": "1341", "journal-title": "J. Infect. Dis.", "key": "10.1016/j.isci.2025.114226_bib13", "volume": "229", "year": "2024" }, { "DOI": "10.1038/s41579-021-00639-z", "article-title": "Infectious disease in an era of global change", "author": "Baker", "doi-asserted-by": "crossref", "first-page": "193", "journal-title": "Nat. Rev. Microbiol.", "key": "10.1016/j.isci.2025.114226_bib14", "volume": "20", "year": "2022" }, { "DOI": "10.1038/s41573-022-00495-3", "article-title": "Antibodies to combat viral infections: development strategies and progress", "author": "Pantaleo", "doi-asserted-by": "crossref", "first-page": "676", "journal-title": "Nat. Rev. Drug Discov.", "key": "10.1016/j.isci.2025.114226_bib15", "volume": "21", "year": "2022" }, { "DOI": "10.1172/JCI166032", "article-title": "Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments", "author": "Gupta", "doi-asserted-by": "crossref", "journal-title": "J. Clin. Investig.", "key": "10.1016/j.isci.2025.114226_bib16", "volume": "133", "year": "2023" }, { "DOI": "10.1016/j.medj.2023.07.007", "article-title": "Sotrovimab therapy elicits antiviral activities against Omicron BQ.1.1 and XBB.1.5 in sera of immunocompromised patients", "author": "Bruel", "doi-asserted-by": "crossref", "first-page": "664", "journal-title": "Med", "key": "10.1016/j.isci.2025.114226_bib17", "volume": "4", "year": "2023" }, { "DOI": "10.1126/scitranslmed.adg2783", "article-title": "Antibody-mediated protection against symptomatic COVID-19 can be achieved at low serum neutralizing titers", "author": "Schmidt", "doi-asserted-by": "crossref", "journal-title": "Sci. Transl. Med.", "key": "10.1016/j.isci.2025.114226_bib18", "volume": "15", "year": "2023" }, { "DOI": "10.1038/s41375-025-02649-9", "article-title": "Post-pandemic recommendations for the management of COVID-19 in patients with haematological malignancies or undergoing cellular therapy, from the European Conference on Infections in Leukaemia (ECIL-10)", "author": "Cesaro", "doi-asserted-by": "crossref", "first-page": "2061", "journal-title": "Leukemia", "key": "10.1016/j.isci.2025.114226_bib19", "volume": "39", "year": "2025" }, { "DOI": "10.1016/j.cmi.2025.05.032", "article-title": "Management of COVID-19 in immunocompromised patients: an European Society of Clinical Microbiology and Infectious Diseases consensus document", "author": "Bartoletti", "doi-asserted-by": "crossref", "first-page": "1655", "journal-title": "Clin. Microbiol. Infect.", "key": "10.1016/j.isci.2025.114226_bib20", "volume": "31", "year": "2025" }, { "DOI": "10.1016/S2666-5247(23)00393-2", "article-title": "Effect of molnupiravir on SARS-CoV-2 evolution in immunocompromised patients: a retrospective observational study", "author": "Fountain-Jones", "doi-asserted-by": "crossref", "first-page": "e452", "journal-title": "Lancet Microbe", "key": "10.1016/j.isci.2025.114226_bib21", "volume": "5", "year": "2024" }, { "article-title": "Escape of SARS-CoV-2 Variants KP.1.1, LB.1, and KP.3.3 From Approved Monoclonal Antibodies. Pathog", "author": "Planas", "first-page": "1", "journal-title": "Immun", "key": "10.1016/j.isci.2025.114226_bib22", "volume": "10", "year": "2024" }, { "DOI": "10.1016/S1473-3099(25)00079-9", "article-title": "Virological characteristics of the SARS-CoV-2 LP.8.1 variant", "author": "Chen", "doi-asserted-by": "crossref", "journal-title": "Lancet Infect. Dis.", "key": "10.1016/j.isci.2025.114226_bib23", "volume": "25", "year": "2025" }, { "DOI": "10.1016/S1473-3099(24)00812-0", "article-title": "Sipavibart: when a success changes into a failure", "author": "Focosi", "doi-asserted-by": "crossref", "first-page": "713", "journal-title": "Lancet Infect. Dis.", "key": "10.1016/j.isci.2025.114226_bib24", "volume": "25", "year": "2025" }, { "DOI": "10.1016/j.jinf.2022.06.033", "article-title": "Sotrovimab to prevent severe COVID-19 in high-risk patients infected with Omicron BA.2", "author": "Martin-Blondel", "doi-asserted-by": "crossref", "first-page": "e104", "journal-title": "J. Infect.", "key": "10.1016/j.isci.2025.114226_bib25", "volume": "85", "year": "2022" }, { "DOI": "10.1056/NEJMoa2108163", "article-title": "REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19", "author": "Weinreich", "doi-asserted-by": "crossref", "journal-title": "N. Engl. J. Med.", "key": "10.1016/j.isci.2025.114226_bib26", "volume": "385", "year": "2021" }, { "DOI": "10.1056/NEJMoa2107934", "article-title": "Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab", "author": "Gupta", "doi-asserted-by": "crossref", "first-page": "1941", "journal-title": "N. Engl. J. Med.", "key": "10.1016/j.isci.2025.114226_bib27", "volume": "385", "year": "2021" }, { "DOI": "10.1016/S2213-2600(22)00180-1", "article-title": "Efficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial", "author": "Montgomery", "doi-asserted-by": "crossref", "first-page": "985", "journal-title": "Lancet Respir. Med.", "key": "10.1016/j.isci.2025.114226_bib28", "volume": "10", "year": "2022" }, { "DOI": "10.1056/NEJMoa2118542", "article-title": "Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19", "author": "Hammond", "doi-asserted-by": "crossref", "first-page": "1397", "journal-title": "N. Engl. J. Med.", "key": "10.1016/j.isci.2025.114226_bib29", "volume": "386", "year": "2022" }, { "DOI": "10.1056/NEJMoa2116846", "article-title": "Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients", "author": "Gottlieb", "doi-asserted-by": "crossref", "first-page": "305", "journal-title": "N. Engl. J. Med.", "key": "10.1016/j.isci.2025.114226_bib30", "volume": "386", "year": "2022" }, { "DOI": "10.1038/s41467-024-44804-3", "article-title": "Utility of long-read sequencing for All of Us", "author": "Mahmoud", "doi-asserted-by": "crossref", "first-page": "837", "journal-title": "Nat. Commun.", "key": "10.1016/j.isci.2025.114226_bib31", "volume": "15", "year": "2024" }, { "DOI": "10.1038/s41592-023-01993-x", "article-title": "Scalable Nanopore sequencing of human genomes provides a comprehensive view of haplotype-resolved variation and methylation", "author": "Kolmogorov", "doi-asserted-by": "crossref", "first-page": "1483", "journal-title": "Nat. Methods", "key": "10.1016/j.isci.2025.114226_bib32", "volume": "20", "year": "2023" }, { "DOI": "10.1038/s43588-022-00387-x", "article-title": "Symphonizing pileup and full-alignment for deep learning-based long-read variant calling", "author": "Zheng", "doi-asserted-by": "crossref", "first-page": "797", "journal-title": "Nat. Comput. Sci.", "key": "10.1016/j.isci.2025.114226_bib33", "volume": "2", "year": "2022" }, { "DOI": "10.1038/s41586-021-04389-z", "article-title": "Considerable escape of SARS-CoV-2 Omicron to antibody neutralization", "author": "Planas", "doi-asserted-by": "crossref", "first-page": "671", "journal-title": "Nature", "key": "10.1016/j.isci.2025.114226_bib34", "volume": "602", "year": "2022" }, { "DOI": "10.1038/s41586-021-03777-9", "article-title": "Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization", "author": "Planas", "doi-asserted-by": "crossref", "first-page": "276", "journal-title": "Nature", "key": "10.1016/j.isci.2025.114226_bib35", "volume": "596", "year": "2021" }, { "DOI": "10.1038/s41591-022-01792-5", "article-title": "Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies", "author": "Bruel", "doi-asserted-by": "crossref", "first-page": "1297", "journal-title": "Nat. Med.", "key": "10.1016/j.isci.2025.114226_bib36", "volume": "28", "year": "2022" }, { "article-title": "Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal antibodies", "author": "Bruel", "journal-title": "Cell Rep. Med.", "key": "10.1016/j.isci.2025.114226_bib37", "volume": "3", "year": "2022" }, { "DOI": "10.1038/s41591-021-01318-5", "article-title": "Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies", "author": "Planas", "doi-asserted-by": "crossref", "first-page": "917", "journal-title": "Nat. Med.", "key": "10.1016/j.isci.2025.114226_bib38", "volume": "27", "year": "2021" }, { "article-title": "Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies", "author": "Dufloo", "journal-title": "Cell Rep. Med.", "key": "10.1016/j.isci.2025.114226_bib39", "volume": "2", "year": "2021" }, { "DOI": "10.1016/j.jinf.2022.04.010", "article-title": "Outcome of very high-risk patients treated by Sotrovimab for mild-to-moderate COVID-19 Omicron, a prospective cohort study (the ANRS 0003S COCOPREV study)", "author": "Martin-Blondel", "doi-asserted-by": "crossref", "first-page": "e101", "journal-title": "J Infection", "key": "10.1016/j.isci.2025.114226_bib40", "volume": "84", "year": "2022" } ], "reference-count": 40, "references-count": 40, "relation": {}, "resource": { "primary": { "URL": "https://linkinghub.elsevier.com/retrieve/pii/S2589004225024873" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "Viral clearance and escape during therapy of COVID-19 outpatients: A prospective cohort study", "type": "journal-article", "update-policy": "https://doi.org/10.1016/elsevier_cm_policy", "volume": "28" }